Analysis of genotype and haplotype effects of ABCB1 (MDR1) polymorphisms in the risk of medically refractory epilepsy in an indian population

Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 3, 2009, Pages 255-260

  Vahab, Saadi Abdul ^a   Sen, Supratim ^b   Ravindran, Nivedita ^a   Mony, Sridevi ^a   Mathew, Anila ^c   Vuayan, Neetha ^c   Nayak, Geetha ^a   Bhaskaranand, Nalini ^b   Banerjee, Moinak ^c   Satyamoorthy, Kapaettu ^a  

^a MANIPAL UNIVERSITY   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

^c RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

ABCB1; Allele; Association; Epilepsy; Haplotype; Refractory

Indexed keywords

CARBAMAZEPINE; GENOMIC DNA; MULTIDRUG RESISTANCE PROTEIN 1; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DNA SEQUENCE; DRUG RESPONSE; EPILEPSY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; HUMAN CELL; INDIAN; INFANT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 69949133732     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.24.255     Document Type: Article

References (20)

1. Udani, V.: Pediatric epilepsy - an Indian perspective. Indian J. Pediatr., 72: 309-313 (2005).
2. Berg, A. T. and Kelly, M. M.: Defining intractability: comparisons among published definitions. Epilepsia, 47: 431-436 (2006).
3. Remy, S. and Beck, H.: Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain, 129, 18-35 (2006).
4. Marchi, N., Hallene, K. L., Kight, K. M., Cucullo, L., Moddel, G., Bingaman, W., Dini, G., Vezzani, A. and Janigro, D.: Significance of MDR1 and multiple drug resistance in refractory human epileptic brain. BMC Med., 2: 37 (2004).
5. Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N., Annett, G. M. and Raffel, C.: MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia, 36: 1-6 (1995).
6. Sisodiya, S. M., Lin, W. R., Harding, B. N., Squier, M. V. and Thom, M.: Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain., 125: 22-31 (2002).
7. Dean, M., Rzhetsky, A. and Allikmets, R.: The human ATP-binding cassette (ABC) transporter superfamily. Genome Res., 11: 1156-1166 (2001).
8. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M. and Brinkmann, U.: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci., USA, 97: 3473-3478 (2000).
9. Wang, D. and Sadee, W.: Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1). AAPS J., 8: E515-520 (2006).
10. Zimprich, F., Sunder-Plassmann, R., Stogmann, E., Gleiss, A., Dal-Bianco, A., Zimprich, A., Plumer, S., Baumgartner, C. and Mannhalter, C.: Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy. Neurology, 63: 1087-1089 (2004).
11. Kwan, P., Baum, L.,Wong, V., Ng, P. W., Lui, C. H., Sin, N. C., Hui, A. C., Yu, E. and Wong, L. K.: Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav., 11: 112-117 (2007).
12. Shahwan, A., Murphy, K., Doherty, C., Cavalleri, G. L., Muckian, C., Dicker, P., McCarthy, M., Kinirons, P., Goldstein, D. and Delanty, N.: The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Epilepsy Res., 73: 192-198 (2007).
13. Kim, D. W., Kim, M., Lee, S. K., Kang, R. and Lee, S. Y.: Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy. Seizure, 15: 344-347 (2006).
14. Siddiqui, A., Kerb, R., Weale, M. E., Brinkmann, U., Smith, A., Goldstein, D. B., Wood, N. W. and Sisodiya, S. M.: Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N. Engl. J. Med., 348: 1442-1448 (2003).
15. Tan, N. C., Heron, S. E., Scheffer, I. E., Pelekanos, J. T., McMahon, J. M., Vears, D. F., Mulley, J. C. and Berkovic, S. F.: Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology, 63: 1090-1092 (2004).
16. Cascorbi, I., Gerloff, T., Johne, A., Meisel, C., Hoffmeyer, S., Schwab, M., Schaeffeler, E., Eichelbaum, M., Brinkmann, U. and Roots, I.: Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin. Pharmacol. Ther., 69: 169-174 (2001).
17. Dudbridge, F.: Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol., 25: 115-121 (2003).
18. Hung, C. C., Tai, J. J., Lin, C. J., Lee, M. J. and Liou, H. H.: Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response. Pharmacogenomics, 6: 411-417 (2005).
19. Loscher, W. and Schmidt, D.: New Horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res, 69: 183-272 (2006).
20. Owen, A., Pirmohamed, M., Tettey, J.N., Morgan, P., Chadwick, D. and Park, B. K.: Carbamazepine is not a substrate for P-glycoprotein. Br. J. Clin. Pharmacol., 51: 345-349 (2001).